Filter
434
Filtered Results: 434
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
58
New Publications
131
Language
Document type
No document type
222
Guidelines
85
Studies & Reports
55
Strategic & Response Plan
26
Manuals
25
Fact sheets
8
Training Material
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Videos
1
Countries / Regions
Kenya
26
South Africa
16
India
16
Ghana
15
Nigeria
15
Uganda
15
Western and Central Europe
14
Global
13
Eastern Europe
11
Ethiopia
11
Nepal
10
Rwanda
10
Namibia
10
Sierra Leone
8
Malawi
8
Tanzania
8
Zambia
8
Latin America and the Carribbean
6
South–East Asia Region
6
Senegal
5
Philippines
5
Cambodia
5
Bangladesh
5
Botswana
5
Liberia
5
Africa
4
West and Central Africa
4
East and Southern Africa
4
Russia
4
Lesotho
3
Zimbabwe
3
Mozambique
3
Middle East and North Africa
3
Haiti
2
Asia
2
Congo, Democratic Republic of
2
Eastern Europe and Central Asia
2
Lebanon
2
Brazil
2
Sudan
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Ukraine
1
Benin
1
Gambia
1
Cameroon
1
Syria
1
Laos
1
Burkina Faso
1
Afghanistan
1
Morocco
1
Jordan
1
Western Pacific Region
1
Paraguay
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
217
Clinical Guidelines
52
Public Health
13
Women & Child Health
8
Pharmacy & Technologies
8
Key Resources
6
Capacity Building
5
Toolboxes
TB
51
Pharmacy
47
AMR
41
COVID-19
29
HIV
22
NTDs
20
Malaria
20
Planetary Health
4
NCDs
4
Rapid Response
3
Caregiver
3
Refugee
2
Specific Hazards
1
Cholera
1
Ebola & Marburg
1
Zika
1
Polio
1
Global Health Education
1
Third Edition: Revised October 2012
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-frie...
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
5th edition.
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen...
